Professional Documents
Culture Documents
Sectoral Issues in Industry
Sectoral Issues in Industry
FOR MAINS
Sectoral Issues in Industry
Topics to be covered
Electronics
Sector
Sectoral Semi-
Textile
Sector
Issues in conductor
Industry Industry
Pharmaceu
tical Sector
Electronics Sector
Government Issues /
Initiatives Challenges
Electronics Sector
• Domestic production has grown from USD 29 billion in 2014-15 to nearly USD 70 billion in
2019-20 (Compounded Annual Growth Rate of 25%).
• Furthermore, continuing on the path of import substitution, India's domestic electronics
market is estimated to reach at best USD150-180 billion from the current USD65 billion
over the next 4-5 years.
• Thus, exports of USD120-140 billion are critical to reach the USD300 billion mark for
electronics manufacturing.
• This, in turn, is key for the USD5 trillion economy, USD 1 trillion digital economy, and the
USD 1 trillion export target envisaged by MeitY (Ministry of Electronics and Information
Technology) and the Ministry of Commerce and Industry, respectively.
Why & Government Initiatives
Why? = Benefits + Potential Govt. Initiatives
Economic Reasons
• Rapid Growth = Production & Exports • Modified Special Incentive Package
• Labour intensive manufacturing Scheme (M-SIPS)
• Employment Generation = 4 crore jobs by 2025 & 8 crore by 2030. • National Policy on Electronics, 2019
• Integration with the Global Value Chain (GVCs) = High export • Declared as ‘Priority sector’ under
potential Make in India.
• Rising market demand (Industry 4.0) • 100% FDI in the electronics sector.
• Diversification of economy (Agriculture – Knowledge Economy) • Electronics Development Fund (EDF)
• Attracting foreign investment such as Samsung, Amazon.
• Electronics Manufacturing Cluster
• Import substitution (Decline of CAD)
Scheme 2.0
• Replacing the position of China.
• Production Linked Incentive Scheme
Other Benefits – Social, Technological & Strategic
(PLI)
• Atmanirbhar Bharat
• Industry-Academia convergence
• Boost skill development such as cloud computing, AI, machine
learning.
• Indigenous manufacturing is key in defence & aerospace.
• Facilitate the spread of 5G technology and boost ICT sector
• Boost R&D in the country.
Challenges & Suggestions
Challenges Suggestions
Government Issues /
Initiatives Challenges
Current Status
• India currently imports all chips and the market is estimated to touch $100 billion by 2025
from $24 billion now.
• The semiconductor industry is not evenly distributed and is dominated by a few countries,
mainly U.S., Taiwan, South Korea, Japan, China, and Europe.
• There is no single region with the entire production stack in its territory.
• Companies across the semiconductor value chain operate in different processes and
technologies (like design, fabrication, and assembly) in pursuit of economic efficiency.
• However, no region has achieved strategic autonomy in the industry. The US companies
rely on foundries in Taiwan to manufacture the chips.
• Thus, the technological complexity and need for scale have led to the emergence of a large
number of players with business models focused on a specific layer of the semiconductor
value chain
Why & Government Initiatives
Why? = Benefits + Potential Govt. Initiatives
Economic Reasons
• Make in India – Global hub for
• Heart and brain of all modern electronics and ICT products. Electronic System Design and
Lifeblood of the modern information age.
Manufacturing (ESDM)
• Hike in Demand – Covid-19 + WFH + Industry 4.0
• Global scramble for the same raw material (Electric
• Production Linked Incentive (PLI)
vehicles) Scheme
• Industry 4.0 – AI, IoT, 5G or the automotive sector. • Design Linked Incentive Scheme (DLI)
• India’s semi-conductor demand – Imports all chips • Digital RISC-V (DIR-V) program
• Multiplier effect on the entire economy (value chain for
semiconductors)
• India Semiconductor Mission
• Semicon India - $10 bn fiscal and non-
Other Reasons fiscal support.
Government Issues /
Initiatives Challenges
Current Status
• India is the largest provider of generic drugs globally. It supplies over 50% of global demand for various
vaccines, 40% of generic demand in the US and 25% of all medicine in the UK.
• The Indian pharmaceutical market is estimated at USD 40 billion and pharma companies export another USD
20 billion generating a trade surplus.
• However, this is a miniscule portion of the USD 1.27-trillion global pharmaceutical market.
• Over 80% of the antiretroviral drugs used globally to combat AIDS (Acquired Immune Deficiency Syndrome)
are supplied by Indian pharmaceutical firms.
• Globally, India ranks 3rd in terms of pharmaceutical production by volume and 14th by value.
• India has more than 30% share in the global generic market but less than 1% share in the new molecular entity
space.
• New Molecular Entity: A novel compound that has not previously been approved for use in humans.
• Price competitiveness and good quality has enabled Indian medicines producers to be dominant players in the
world market, thereby making the country the “Pharmacy of the world”.
• Although a prominent player in formulations, the country is significantly dependent on the import of bulk
drugs that are used in the formulation of medicine. In certain cases, import dependence varies between 80-
100 percent
Current Status
Why & Government Initiatives
Why? = Benefits + Potential Govt. Initiatives
Benefits
• Tapping the potential of Demographic Dividend. • Scheme for the promotion of Bulk Drug
• Longevity dividend --> Healthy ageing population Parks (3)
• Trade surplus • PLI Scheme for Bulk Drugs
• Medical Tourism • PLI Scheme for Pharmaceuticals
• Universal Health Coverage – SDG 3 (Affordable • PLI Scheme for promoting Domestic
Quality healthcare for All) Manufacturing of Medical Devices
• Rising burden of NCDs • First Global Innovation Summit pf the
• Soft Power pharmaceuticals sector, 2021.
Potential
• One of the lowest manufacturing cost. (33% lower than
that of US)
• Medical Diplomacy
• Export Potential
• High economic growth + Increasing health insurance
• Policy support
• Increasing investments especially in post-pandemic world
Challenges & Suggestions
Challenges Suggestions
Challenges
• Increasing value share in global basket.
• Low public expenditure on R&D - 1% less than China (2.1%), (Volume + Value Share) – Emerging
Brazil (1.3%)
opportunities: biosimilars, mRNA and other
• Lack of funding
new-generation vaccines.
• Lack of Capabilities in Innovation Space – Lags in innovation
infrastructure. • Targeted financial incentives →
• Import of Active Pharmaceutical Ingredients (APIs) – 80% from Manufacturing of diagnostic kits and other
China ---> Supply disruptions and uncertain price fluctuations. medical devices.
• ‘Hollowing out’ manufacturing in India • Boost R&D investment: 1% increase in R&D
• Quality Compliance Inquiry – Highest number of FDA → Rise in output between 0.05 – 0.15%.
inspections since 2009. • Invest in research initiatives and talent to
• Spurious medicines (Harmful FDCs in the market) grow India’s innovation.
• Stronger IP regulations – TRIPs+ • Research Linked Incentives (RLIs) =
• Price Capping – Impacts the net profits of the pharma
Investments + Academia – Industry linkages
companies.
• Fragmented regulation – lack of coordination between central
• Boost to the domestic production to APIs
and state drug control organisations. • Continuous investment for upgrading
• Unregulated online pharmacies quality standards
• Unethical practices by big pharma companies and inherent • Better Drug Pricing policy – Developing new
profit motive. molecules
Textile Sector
• Improving the size of firms. (Scale ) -->
CoP + Productivity = Global benchmarks
• Mega apparel parks (Organised sector)
Textiles Sector • Higher GDP growth for the country
• 7% of the industrial output.
• Modernisation of the obsolete
• Labour-intensive sector especially women.
machinery and technology
(>21% of the total employment)
• Comprehensive blueprint for the textiles
sector • Export earnings. (12% of export). ---> USD 1
• Environment friendly manufacturing billion exports = 1.5 lakh new jobs.
• Specialisation – Focus on man-made • 6th largest producer of technical textiles.
fiber apparel manufacturing (Global Way Status and • 2nd largest producer of silk in the world.
fashion demands) • Largest producer of cotton and jute in the
• Logistics infrastructure Forward Potential world.
• Resource mobilisation
• FTAs with countries to boost exports
• Amended Technology Upgradation • Highly fragmented (Unorganised sector)
Fund Scheme (2015) • Outdated technology (== Global standards)
• Scheme for Integrated Textile Parks
(SITP)
Govt. Issues / • Tax Structure --> GST = Expensive garments
• Rising labour wages and worker’s salaries.
• SAMARTH (Scheme For Capacity Initiatives Challenges • Lack of economies of scale --> Mushrooming
Building In Textile Sector)
of 1 person apparel firms (Small size of firms)
• Power-Tex India
• Silk Samagra Scheme • Limited FDI to the sector.
• National Technical Textiles Mission • Stagnating exports
• PLI Scheme for Textiles Sector • Inflexible labour laws (high min. wages, etc.)
• HSN Codes for Technical Textiles • Poor logistics infrastructure --> High costs
• 100% FDI under Automatic route
• New Textiles Policy, 2020 • Discrimination in export markets.